Tenon Medical (NASDAQ:TNON) & Treace Medical Concepts (NASDAQ:TMCI) Head to Head Survey

Tenon Medical (NASDAQ:TNON) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations and institutional ownership.

Earnings and Valuation

This table compares Tenon Medical and Treace Medical Concepts”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.28 million	3.76	-$13.67 million	($27.23)	-0.05
Treace Medical Concepts	$209.36 million	2.25	-$55.74 million	($0.79)	-9.46

Tenon Medical has higher earnings, but lower revenue than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Tenon Medical and Treace Medical Concepts, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	0	0	3	0	3.00
Treace Medical Concepts	0	4	2	0	2.33

Tenon Medical currently has a consensus price target of $5.50, suggesting a potential upside of 295.68%. Treace Medical Concepts has a consensus price target of $9.8333, suggesting a potential upside of 31.64%. Given Tenon Medical’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Tenon Medical is more favorable than Treace Medical Concepts.

Institutional and Insider Ownership

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 0.3% of Tenon Medical shares are held by insiders. Comparatively, 27.7% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Tenon Medical and Treace Medical Concepts’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-429.45%	-332.11%	-106.82%
Treace Medical Concepts	-23.01%	-46.76%	-23.35%

Volatility & Risk

Tenon Medical has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500.

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About Treace Medical Concepts

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.